Staging and reporting of urothelial carcinoma of the urinary bladder

Modern Pathology

Volumn 22, Issue , 2009, Pages S70-S95

  Cheng, Liang ^a   Montironi, Rodolfo ^b   Davidson, Darrell D ^a   Lopez Beltran, Antonio ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Neoplasia classification; PT1 substaging; Specimen handling and Reporting; TNM staging; Urinary bladder

Indexed keywords

CYTOKERATIN 20; MESSENGER RNA; UROPLAKIN;

BLADDER BIOPSY; BLADDER CANCER; BLADDER TUMOR; CANCER CLASSIFICATION; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL LABORATORY; CYSTECTOMY; HISTOLOGY; HUMAN; LABORATORY DIAGNOSIS; LAMINA PROPRIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS; MULTIPLE CANCER; OUTCOMES RESEARCH; PELVIS EXENTERATION; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSURETHRAL RESECTION; TUMOR GROWTH; URACHUS; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; HUMANS; NEOPLASM STAGING; PATHOLOGY, SURGICAL; SPECIMEN HANDLING; URINARY BLADDER NEOPLASMS;

EID: 67149116512     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.1     Document Type: Article

References (150)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Droller MJ. Bladder cancer: State-of-the-art care. CA Cancer J Clin 1998;48:269-284.
3. Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer 2000;88:2326-2332.
4. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 2001;19:666-675.
5. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111-1116.
6. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176:2414-2422.
7. Soloway MS. It is time to abandon the ‘superficial’ in bladder cancer. Eur Urol 2007;52:1564-1565.
8. Nieder AM, Soloway MS. Eliminate the term ‘superficial’ bladder cancer. J Urol 2006;175:417-418.
9. Greene FL, Page DL, Flemming ID, et al. American Joint Committee on Cancer Staging Manual. Springer-Verlag: New York, 2002.
10. Palapattu GS, Shariat SF, Karakiewicz PI, et al. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 2006;175: 1645-1649.
11. Kassouf W, Spiess PE, Brown GA, et al. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol 2007;52:769-774.
12. Thrasher JB, Frazier HA, Robertson JE, et al. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol 1994;152:393-396.
13. Volkmer BG, Kuefer R, Bartsch Jr G, et al. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 2005;104:2384-2391.
14. Yiou R, Patard JJ, Benhard H, et al. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 2002;89: 374-378.
15. Maclennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 2007;51:889-898.
16. Lopez-Beltran A, Cheng L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 2003;35:484-491.
17. Mhawech P, Iselin C, Pelte MF. Value of immunohistochemistry in staging T1 urothelial bladder carcinoma. Eur Urol 2002;42:459-463.
18. Jimenez RE, Keany TE, Hardy HT, et al. pT1 Urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clionical implications. Adv Anat Pathol 2000;7:13-25.
19. Andius P, Johansson SL, Holmañg S. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion. Urology 2007;70:758-762.
20. Tamas EF, Epstein JI. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 2007;31:390-397.
21. Tosoni I, Wagner U, Sauter G, et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000;85:48-53.
22. Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003;169:1291-1294.
23. Nieder AM, Brausi M, Lamm D, et al. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology 2005;66:108-125.
24. Cheng L, Bostwick DG. Progression of T1 bladder tumors: better staging or better biology. Cancer 1999;86:910-912.
25. Cheng L, Neumann RM, Weaver AL, et al. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999;17:3182-3187.
26. Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000;113:275-279.
27. Soloway MS, Lee CT, Steinberg GD, et al. Difficult decisions in urologic oncology: management of highgrade T1 transitional cell carcinoma of the bladder. Urol Oncol 2007;25:338-340.
28. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007;177:75-79.
29. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005;174:2134-2137.
30. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 2002;167:1573-1583.
31. Angulo JC, Lopez JI, Grignon DJ, et al. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995;45:47-53.
32. Hasui Y, Osada Y, Kitada S, et al. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994;43:782-786.
33. Hermann GG, Horn T, Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998;159:91-94.
34. Holmang S, Hedelin H, Anderstrom C, et al. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997;157:800-804.
35. Platz CE, Cohen MB, Jones MP, et al. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996;11:1035-1039.
36. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990;66:543-548.
37. Sozen S, Akbal C, Sokmensuer C, et al. Microstaging of pT1 transitional cell carcinoma of the bladder: does it really differentiate two populations with different prognoses? Urol Int 2002;69:200-206.
38. Cheng L, Weaver AL, Neumann RM, et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. A new proposal. Cancer 1999;86:1035-1043.
39. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 1983;136:265-271.
40. Keep JC, Piehl M, Miller A, et al. Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 1989;91: 575-579.
41. Ro JY, Ayala AG, el-Naggar A. Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 1987;11:668-673.
42. Engel P, Anagnostaki L, Braendstrup O. The muscularis mucosae of the human urinary bladder. Scand J Urol Nephrol 1992;26:249-252.
43. Kondylis FI, Demirci S, Ladaga L, et al. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000;163:1120-1123.
44. Paner GP, Ro JY, Wojcik EM, et al. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2007;31: 1420-1429.
45. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-1448.
46. Cheng L, Weaver AL, Bostwick DG. Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens. Urology 2000;55:668-672.
47. Farrow G, Utz D, Rife C. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 1976; 36:2495-2501.
48. Farrow G, Utz D, Rife C, et al. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 1977;37:2794-2798.
49. Farrow GM, Utz DC. Observation on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol 1982;1:609-615.
50. McKenney JK, Gomez JA, Desai S, et al. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 2001;25:356-362.
51. Lopez-Beltran A, Cheng L, Andersson L, et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation. Virchows Arch 2002;440:3-11.
52. Jewett HJ. Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 1952;67:672-680.
53. Bayraktar ZGG, Ihsan AT, Sevin G. Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy. Int J Urol Nephrol 2002;33:627-629.
54. Herr HW. Staging invasive bladder tumors. J Surg Oncol 1992;51:217-220.
55. Herr HW. A propsed simplified staging system of invasive bladder tumors. Urol Int 1993;50:17-20.
56. Hall RR, Prout GR. Staging of bladder cancer: is the tumor, node, metastasis system adequate? Semin Oncol 1990;17:517-523.
57. Skinner DG. Current state of classification and staging of bladder cancer. Cancer Res 1977;37:2838-2842.
58. Skinner DG. Current perspectives in the management of high grade invasive bladder cancer. Cancer 1980;45:1866-1874.
59. Cummings KB, Barone JG, Ward WS. Diagnosis and staging of bladder cancer. Urol Clin North Am 1992;19:455-465.
60. Bowles WT, Cordonnier JJ. Total cystectomy for carcinoma of the bladder. J Urol 1963;90:731-735.
61. Cox CE, Cass AS, Boyce WH. Bladder cancer: a 26-year review. Trans Am Assoc Genitourin Surg 1968;60:22-30.
62. Boileau MA, Johnson DE, Chan RC, et al. Bladder Carcinoma. Results with preoperative radiation therapy and radical cystectomy. Urology 1980;16:569.
63. Beahrs JR, Fleming TR, Zincke H. Risk of local urethral recurrence after radical cystectomy for bladder cancer. J Urol 1984;131:264-266.
64. Bredael JJ, Croker BP, Glenn JF. The curability of invasive bladder cancer treated by radical cystectomy. Eur Urol 1980;6:206-210.
65. Cordonnier JJ. Simple cystectomy in the management of bladder carcinoma. Arch Surg 1974;108:190-191.
66. Mathur VK, Krahn HP, Ramsey EW. Total cystectomy for bladder cancer. J Urol 1981;125:784-786.
67. Pollack A, Zagars GK, Cole CJ, et al. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 1995;154:2059-2064.
68. Pomerance A. Pathology and prognosis following total cystectomy for carcinoma of bladder. Br J Urol 1972;44:451-458.
69. Prout GRJ. The surgical management of bladder carcinoma. Urol Clin N Am 1976;3:149-175.
70. Richie JP, Skinner DG, Kaufman JJ. Radical cystectomy for carcinoma of the bladder:16 years of experience. J Urol 1975;113:186-189.
71. Richie JP, Skinner DG, Kaufman JJ. Carcinoma of the bladder: treatment by radical cystectomy. J Surg Res 1975;18:271-275.
72. Roehrborn CG, Sagalowsky AI, Peters PC. Long-term patient survival after cystectomy for regional metastastic transitional cell carcinoma of the bladder. J Urol 1991;146:36-39.
73. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982;128:34-36.
74. Sorensen BL, Ohlsen AS, Barlebo H. Carcinoma of the urinary bladder. Clinical staging and histologic grading in relation to survival. Scand J Urol Nephrol 1969;3:189-192.
75. Utz DC, Schmitz SE, Fugelso PD, et al. A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder. Cancer 1975;32: 1075-1077.
76. Whitemore WF. Management of invasive bladder neoplasms. Semin Urol 1983;1:34-41.
77. Wishnow KI, Levinson AK, Johnson DE, et al. Stage B (P 2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomy. Urology 1992;39:12-16.
78. Pearse HD, Reed RR, Hodges CV. Radical cystectomy for bladder cancer. J Urol 1978;119:216-218.
79. Montie JE, Straffon RA, Stewart BH. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984;131:477-482.
80. Pagano F, Bassi P, Galetti TP, et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
81. Yu RJ, Stein JP, Cai J, et al. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 2006;176:493-499.
82. Girgin C, Sezer A, Delibas M, et al. Impact of the level of muscle invasion in organ-confined bladder cancer. Urol Int 2007;78:145-149.
83. Skinner DG, Tift JP, Kaufman JJ. High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol 1982;127:671-674.
84. Cuesta JA, Chapado MS, Cid MG, et al. Survival of patients with stage T2-T3a bladder cancer treated by radical cystectomy. Arch Esp De Urol 1997;50:17-25.
85. Cheng L, Neumann RM, Scherer BG, et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999;85: 2638-2647.
86. Tokgoz H, Turkolmez K, Resorlu B, et al. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary? Int Braz J Urol 2007;33:777-783.
87. Jewett HJ. Editorial: Comments on the staging of invasive bladder cancer two B’s or not to B’s: That is the question. J Urol 1978;119:39.
88. Philip AT, Amin MB, Tamboli P, et al. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol 2000;24:1286-1290.
89. Quek ML, Stein JP, Clark PE, et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol 2004;171:640-645.
90. Bastian PJ, Hutterer GC, Shariat SF, et al. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int 2008;101:450-454.
91. Palou J, Baniel J, Klotz L, et al. Urothelial carcinoma of the prostate. Urology 2007;1(Suppl):50-61.
92. Donat SM, Genega EM, Herr HW, et al. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001;165: 1117-1120.
93. Esrig D, Freeman JA, Elmajian DA, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996;156:1071-1076.
94. Pagano F, Bassi P, Ferrante GL, et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996;155:244-247.
95. Shen SS, Lerner SP, Muezzinoglu B, et al. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006;37:726-734.
96. Montironi R, Cheng L, Mazzucchelli R, et al. Critical pathological evaluation of the prostate from cystoprostatectomies for bladder cancer: Insights from complete sampling with the whole mount technique. Eur Urol 2009 (in press).
97. Daneshmand S, Stein JP, Lesser T, et al. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder. J Urol 2004;2004:81-84.
98. Volkmer BG, Ku¨ fer R, Maier S, et al. Outcome in patients with seminal vesicle invasion after radical cystectomy. J Urol 2003;169:1299-1302.
99. Murphy WM, Crissman JD, Johansson SL, et al. Recommendations for the reporting of urinary bladder specimens that contain bladder neoplasms. Mod Pathol 1996;9:796-798.
100. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169: 943-945.
101. Kassouf W, Agarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008;26:121-126.
102. Stein JP, Cai J, Groshen S, et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003;170:35-41.
103. Kassouf W, Leibovici D, Munsell MF, et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 2006;176:53-57.
104. Fleischmann A, Thalmann GN, Markwalder R, et al. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005;23:2358-2365.
105. Frank I, Cheville JC, Blute ML, et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer 2003;97:2425-2431.
106. Fleischmann A, Thalmann GN, Markwalder R, et al. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 2005;29: 89-95.
107. Wu X, Kakehi Y, Zeng Y, et al. Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: Comparison with cytokeratin 20. J Urol 2005;174:2138-2143.
108. Seraj MJ, Thomas AR, Chin JL, et al. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder. Clin Cancer Res 2001;7:1516-1522.
109. Copp HL, Chin JL, Conaway M, et al. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma. Cancer 2006;107:60-66.
110. Marin-Aguilera M, Mengual L, Burset M, et al. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol 2008;54:1363-1372.
111. Yang XJ, Lecksell K, Epstein JI. Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder? Am J Clin Pathol 1999;112:649-653.
112. Lopez-Beltran A, Bassi P, Pavone-Macaluso M, et al. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 2004;45:257-266.
113. Amin MB, Srigley JR, Grignon DJ, et al. Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis. Arch Pathol Lab Med 2003;127:1263-1279.
114. Recommendations for the reporting of urinary bladder specimens containing bladder neoplasms. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 1996;27:751-753.
115. Herr HW, Faulkner JR, Grossman HB, et al. Pathologic evaluation of radical cystectomy specimens: a cooperative group report. Cancer 2004;100:2470-2475.
116. Bostwick DG, Ramnani DM, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin N Am 1999;26:493-507.
117. Lopez-Beltran A, Bollito E, Luque RJ, et al. A practical approach to bladder sampling and diagnostic reporting of pathological findings. Pathologica 2001;93:688-692.
118. Lapham RL, Grignon D, Ro JY. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 1997;14:109-122.
119. Hammond EH, Henson DE. Practice protocol for the examination of specimens removed from patients with carcinoma of the urinary bladder, ureter, renal pelvis, and urethra. Arch Pathol Lab Med 1996;120: 1103-1110.
120. Murphy WM. ASCP survey on anatomic pathology examination of the urinary bladder. Am J Clin Pathol 1994;102:715-723.
121. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66:4-34.
122. Rosai J. Appendix E Guidelines for handling of most common and important surgical specimens Rosai and Ackerman’s Surgical Pathology. Mosby/Elsevier: Philadelphia, 2004;2911-2977.
123. Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006;37:1371-1388.
124. Reuter VE. The pathology of bladder cancer. Urology 2006;67:11-18.
125. Reuter VE. Bladder. Risk and prognostic factors—a pathologist’s perspective. Urol Clin North Am 1999;26:481-492.
126. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. World Health Organization: Geneva, 1973.
127. Eble JN, Sauter G, Epstein JI, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyon, 2004.
128. Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000;24:980-987.
129. Langner C, Hutterer G, Chromecki T, et al. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 2006;448:604-611.
130. Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progressioin and recurrence. J Urol 1983;130:1083-1086.
131. Fung CF, Shipley WU, Young RH, et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 1991;9:1533-1542.
132. Koss LG, Tiamson EM, Robbins MA. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 1974;227:281-286.
133. Weinstein RS. Origin and dissemination of human urinary bladder carcinoma. Semin Oncol 1979;6: 149-156.
134. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982;127:250-252.
135. Kiemeney LA, Witjes JA, Heijbroek RP, et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993;150:60-64.
136. Koss LG. Mapping of the urinary bladder: Its impact on the concepts of bladder cancer. Hum Pathol 1979;10:533-548.
137. Koss LG, Nakanishi I, Freed SZ. Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology 1977;9:442-455.
138. Jones TD, Wang M, Eble JN, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005;11:6512-6519.
139. Hartmann A, Rosner U, Schlake G, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 2000;80:709-718.
140. Sidransky EA, Frost P, von Eschenbach A, et al. Clonal origin of bladder cancer. N Engl J Med 1992;326:737-740.
141. Simon R, Eltze E, Schafer KL, et al. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 2001;61:355-362.
142. Parmar MK, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989;142:284-288.
143. Saito K, Kawakami S, Fujii Y, et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007;178:2291-2296.
144. Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and perineural invasion in urothe-lial bladder cancer treated with radical cystectomy. J Urol 2003;169:955-960.
145. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005;23:6533-6539.
146. Quek ML, Stein JP, Nichols PW, et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005;174:103-106.
147. Türkölmez K, Tokgoż H, Resorlu B, et al. Muscleinvasive bladder cancer: Predictive factors and prognostic difference between primary and progressive tumors. Urology 2007;70:477-481.
148. Lopez-Beltra JI, Angulo JC. The prognostic significance of vascular invasion in stage T1 bladder cancer. Histopathology 1995;27:27-33.
149. Hong SK, Kwak C, Jeon HG, et al. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? Urology 2005;65:697-702.
150. Dotan ZA, Kavanagh K, Yossepowitch O, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 2007;178:2308-2312.